Chesnais M, Bujaki E, Filhol T, Caval V, Joffret M, Martin J
Virus Evol. 2024; 10(1):veae063.
PMID: 39170726
PMC: 11336667.
DOI: 10.1093/ve/veae063.
Devaux C, Pontarotti P, Levasseur A, Colson P, Raoult D
Front Public Health. 2024; 11:1284337.
PMID: 38259741
PMC: 10801389.
DOI: 10.3389/fpubh.2023.1284337.
Jorgensen D, Pons-Salort M, Shaw A, Grassly N
Virus Evol. 2020; 6(2):veaa040.
PMID: 32782825
PMC: 7409915.
DOI: 10.1093/ve/veaa040.
Bandyopadhyay A, Asturias E, ORyan M, Oberste M, Weldon W, Clemens R
Vaccine. 2017; 35(52):7283-7291.
PMID: 29150209
PMC: 5725506.
DOI: 10.1016/j.vaccine.2017.11.006.
Wanyoike S, Gonzalez A, Dolan S, Garon J, Veira C, Hampton L
J Infect Dis. 2017; 216(suppl_1):S202-S208.
PMID: 28838168
PMC: 5853297.
DOI: 10.1093/infdis/jiw572.
Importance of Genetics of Viruses in Medical Research.
KOPROWSKI H
Am J Hum Genet. 1959; 11(2 Pt 2):335-51.
PMID: 17948435
PMC: 1932144.
Small-scale trial with Sabin attenuated type 1 poliovirus vaccine in a semi-closed community.
Hoskins J, Hobson D, UDALL V, MADLAND T, GOFFE A, Stuart-Harris C
Br Med J. 1962; 1(5280):747-53.
PMID: 14449180
PMC: 1957909.
DOI: 10.1136/bmj.1.5280.747.
Influence of vaccination with formalin inactivated vaccine upon gastrointestinal infection with polioviruses.
LEPOW M, ROBBINS F, WOODS W
Am J Public Health Nations Health. 1960; 50:531-42.
PMID: 14415906
PMC: 1373308.
DOI: 10.2105/ajph.50.4.531.
CURRENT STATUS OF MEASLES AND ORAL POLIOVIRUS VACCINES.
Macleod D
Can Med Assoc J. 1964; 91:1118-22.
PMID: 14229761
PMC: 1928369.
[PECULIARITIES IN VIRUS EXCRETION AND ANTIBODY FORMATION AFTER ADMINISTRATION OF A "BALANCED" LIVE VACCINE MIXTURE OF POLIOVIRUS TYPES I AND II].
Henigst W, Mueller F, WUERSCHING F
Z Hyg Infektionskr. 1963; 149:383-400.
PMID: 14123271
Viruses of human diseases.
Stuart-Harris C
Br Med J. 1962; 1(5295):1779-88.
PMID: 13917942
PMC: 1959159.
DOI: 10.1136/bmj.1.5295.1779.
Results of a study of the reactogenic and immunogenic properties of live anti-poliomyelitis vaccine.
SMORODINTSEV A, DAVIDENKOVA E, DROBYSHEVSKA YA A, Ilyenko V, Gorev N, Kurnosova L
Bull World Health Organ. 1959; 20:1053-74.
PMID: 13832218
PMC: 2537891.
[Changes in chemical-physical properties of the virus of Teschen disease of swine during the modification process by successive passages in swine kidney cultures].
Mayr A, Strohmaier K, Lorenz R
Arch Gesamte Virusforsch. 1961; 11:183-96.
PMID: 13768621
Vaccination of adults with a British oral poliomyelitis vaccine prepared from Sabin strains.
GOFFE A, Pollock T, Shand F
Br Med J. 1961; 2(5247):272-5.
PMID: 13706303
PMC: 1969598.
DOI: 10.1136/bmj.2.5247.272.
Vaccination against poliomyelitis with attenuated live virus.
Macleod D
Can Med Assoc J. 1959; 80(12):998-1001.
PMID: 13662965
PMC: 1831096.
Large-scale use of Sabin type 2 attenuated poliovirus vaccine in Singapore during a type 1 poliomyelitis epidemic.
Hale J, DORAISINGHAM M, KANAGARATNAM K, Leong K, MONTEIRO E
Br Med J. 1959; 1(5137):1541-9.
PMID: 13662613
PMC: 1993778.
DOI: 10.1136/bmj.1.5137.1541.
A comparative study of the prototypic Hill strain of ECHO virus, type 9, and several Coxsackie-like viruses related to it antigenically.
Archetti I, DUBES G, Wenner H
Arch Gesamte Virusforsch. 1959; 9(1):73-91.
PMID: 13650542
DOI: 10.1007/BF01241005.
Active immunization against poliomyelitis with live attenuated viruses.
VERLINDE J, WILTERDINK J, KRET A
Arch Gesamte Virusforsch. 1959; 8(5):549-64.
PMID: 13650527
DOI: 10.1007/BF01242240.
Changes in virulence of attenuated strains of poliomyelitis virus after passages in cultures of human embryonic tissue.
WESSLEN T, SOURANDER P
Arch Gesamte Virusforsch. 1958; 8(3):360-9.
PMID: 13595664
DOI: 10.1007/BF01243749.
A small-scale trial of type III attenuated living poliovirus vaccine.
CLARKE S, GOFFE A, Stuart-Harris C, HERZOG E
Br Med J. 1958; 2(5106):1188-93.
PMID: 13584894
PMC: 2027242.
DOI: 10.1136/bmj.2.5106.1188.
